Haemonetics Revenue 2011-2025 | HAE
Haemonetics revenue from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Haemonetics Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $1,361 |
| 2024 | $1,309 |
| 2023 | $1,169 |
| 2022 | $993 |
| 2021 | $870 |
| 2020 | $988 |
| 2019 | $968 |
| 2018 | $904 |
| 2017 | $886 |
| 2016 | $909 |
| 2015 | $910 |
| 2014 | $939 |
| 2013 | $892 |
| 2012 | $728 |
| 2011 | $677 |
|
Haemonetics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $327 |
| 2025-06-30 | $321 |
| 2025-03-31 | $331 |
| 2024-12-31 | $349 |
| 2024-09-30 | $346 |
| 2024-06-30 | $336 |
| 2024-03-31 | $343 |
| 2023-12-31 | $336 |
| 2023-09-30 | $318 |
| 2023-06-30 | $311 |
| 2023-03-31 | $304 |
| 2022-12-31 | $305 |
| 2022-09-30 | $297 |
| 2022-06-30 | $261 |
| 2022-03-31 | $265 |
| 2021-12-31 | $260 |
| 2021-09-30 | $240 |
| 2021-06-30 | $229 |
| 2021-03-31 | $225 |
| 2020-12-31 | $240 |
| 2020-09-30 | $209 |
| 2020-06-30 | $196 |
| 2020-03-31 | $238 |
| 2019-12-31 | $259 |
| 2019-09-30 | $253 |
| 2019-06-30 | $238 |
| 2019-03-31 | $249 |
| 2018-12-31 | $247 |
| 2018-09-30 | $242 |
| 2018-06-30 | $229 |
| 2018-03-31 | $234 |
| 2017-12-31 | $234 |
| 2017-09-30 | $225 |
| 2017-06-30 | $211 |
| 2017-03-31 | $228 |
| 2016-12-31 | $228 |
| 2016-09-30 | $220 |
| 2016-06-30 | $210 |
| 2016-03-31 | $242 |
| 2015-12-31 | $233 |
| 2015-09-30 | $220 |
| 2015-06-30 | $213 |
| 2015-03-31 | $226 |
| 2014-12-31 | $232 |
| 2014-09-30 | $228 |
| 2014-06-30 | $224 |
| 2014-03-31 | $241 |
| 2013-12-31 | $242 |
| 2013-09-30 | $236 |
| 2013-06-30 | $220 |
| 2013-03-31 | $250 |
| 2012-12-31 | $247 |
| 2012-09-30 | $218 |
| 2012-06-30 | $176 |
| 2012-03-31 | $187 |
| 2011-12-31 | $191 |
| 2011-09-30 | $179 |
| 2011-06-30 | $171 |
| 2011-03-31 | $170 |
| 2010-12-31 | $177 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.200B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.724B | 25.32 |
| EssilorLuxottica (ESLOY) | France | $166.677B | 0.00 |
| Boston Scientific (BSX) | United States | $148.274B | 33.90 |
| Stryker (SYK) | United States | $136.154B | 27.03 |
| Medtronic (MDT) | Ireland | $118.264B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.513B | 0.00 |
| Agilent Technologies (A) | United States | $41.601B | 26.92 |
| ResMed (RMD) | United States | $36.703B | 25.40 |
| GE HealthCare Technologies (GEHC) | United States | $33.276B | 15.91 |
| Koninklijke Philips (PHG) | Netherlands | $27.125B | 17.72 |
| Terumo (TRUMY) | Japan | $23.970B | 28.40 |
| Insulet (PODD) | United States | $22.513B | 69.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.539B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.183B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.253B | 7.47 |
| Bio-Rad Laboratories (BIO) | United States | $8.242B | 29.64 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| ICU Medical (ICUI) | United States | $3.460B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $3.387B | 10.32 |
| Envista Holdings (NVST) | United States | $3.198B | 18.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.883B | 13.15 |
| Perrigo (PRGO) | Ireland | $1.987B | 4.98 |
| LeMaitre Vascular (LMAT) | United States | $1.965B | 39.64 |
| Curaleaf Holdings (CURLF) | Canada | $1.793B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.774B | 17.72 |
| AtriCure (ATRC) | United States | $1.593B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.449B | 63.49 |
| Tilray Brands (TLRY) | Canada | $1.392B | 0.00 |
| Neogen (NEOG) | United States | $1.391B | 26.67 |
| QuidelOrtho (QDEL) | United States | $1.382B | 8.89 |
| Kestra Medical Technologies (KMTS) | United States | $1.349B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.285B | 18.63 |
| BioLife Solutions (BLFS) | United States | $1.242B | 370.43 |
| InMode (INMD) | Israel | $0.913B | 10.32 |
| Valneva SE (VALN) | France | $0.750B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.497B | 17.10 |
| Verano Holdings (VRNO) | United States | $0.478B | 0.00 |
| SNDL (SNDL) | Canada | $0.468B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| CeriBell (CBLL) | United States | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.425B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.381B | 0.00 |
| Cerus (CERS) | United States | $0.328B | 0.00 |
| Brainsway (BWAY) | Israel | $0.296B | 59.96 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| High Tide (HITI) | Canada | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 151.67 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Owens & Minor (OMI) | United States | $0.246B | 2.47 |
| Viemed Healthcare (VMD) | United States | $0.242B | 19.30 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.206B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 16.22 |
| FitLife Brands (FTLF) | United States | $0.172B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.172B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| Biote (BTMD) | United States | $0.134B | 5.42 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Sharps Technology (STSS) | United States | $0.109B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 11.95 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.10 |
| Nephros (NEPH) | United States | $0.049B | 35.38 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Jin Medical (ZJYL) | China | $0.042B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| Zynex (ZYXI) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.77 |
| Modular Medical (MODD) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |